Algert Global’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,020
| Closed | -$213K | – | 1299 |
|
|
2025
Q1 | $213K | Buy |
+29,020
| New | +$213K | 0.01% | 1075 |
|
|
2024
Q3 | – | Sell |
-10,114
| Closed | -$69K | – | 1461 |
|
|
2024
Q2 | $69K | Buy |
+10,114
| New | +$69K | ﹤0.01% | 1430 |
|
|
2023
Q4 | – | Sell |
-25,480
| Closed | -$80K | – | 1221 |
|
|
2023
Q3 | $80K | Sell |
25,480
-23,750
| -48% | -$74.6K | ﹤0.01% | 1046 |
|
|
2023
Q2 | $254K | Buy |
+49,230
| New | +$254K | 0.01% | 940 |
|
|
2022
Q4 | – | Sell |
-73,590
| Closed | -$305K | – | 1235 |
|
|
2022
Q3 | $305K | Buy |
73,590
+5,310
| +8% | +$22K | 0.02% | 945 |
|
|
2022
Q2 | $274K | Buy |
68,280
+56,423
| +476% | +$226K | 0.02% | 942 |
|
|
2022
Q1 | $59K | Buy |
+11,857
| New | +$59K | ﹤0.01% | 1134 |
|
|
2021
Q4 | – | Sell |
-10,100
| Closed | -$101K | – | 1066 |
|
|
2021
Q3 | $101K | Buy |
+10,100
| New | +$101K | 0.01% | 966 |
|